By Benjamin Chiou
Date: Monday 02 Jun 2025
(Sharecast News) - Drugmaker Indivior has announced plans to cancel its secondary listing in London, just a year after moving its primary listing to the Nasdaq.
By Abigail Townsend
Date: Tuesday 04 Mar 2025
(Sharecast News) - Indivior has further overhauled its board, including reducing its size, following pressure from activist investor Oaktree Capital Management.
No recent information was found.
Currency | US Dollars |
Share Price | $ 24.32 |
Change Today | $ 0.27 |
% Change | 1.12 % |
52 Week High | $24.64 |
52 Week Low | $7.46 |
Volume | 2,705,603 |
Time | Volume / Share Price |
16:00 | 236,048 @ $24.32 |
15:59 | 100 @ $24.31 |
15:59 | 100 @ $24.31 |
15:59 | 200 @ $24.31 |
15:59 | 300 @ $24.31 |
You are here: research